Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Rabusertib | Autophagy | Chk | PDK | TargetMol
Rabusertib (LY2603618) | CHK1 Inhibitor | CAS 911222-45-2 | Selleck ...
Rabusertib (LY2603618) (Rabusertib ; IC-83) | CAS 911222-45-2 | AbMole ...
Rabusertib (LY2603618) | CHK1 Inhibitor | MedChemExpress
Rabusertib | C18H22BrN5O3 | CID 11955855 - PubChem
Rabusertib | 911222-45-2 | Reference standards | Alsachim
Rabusertib (LY2603618) | CHK1 inhibitor | Probechem Biochemicals
Rabusertib (LY2603618, IC-83) | Chk inhibitor | 911222-45-2 | AdooQ®
The combination of rabusertib with carboplatin and cisplatin increases ...
Rabusertib (LY2603618) | 购买Chk 抑制剂 - Selleck
eMolecules Medchem Express / Rabusertib / 5mg / 446264475 / HY-14720 ...
Rabusertib (LY2603618) | Rabusertib (LY2603618)| 911222-45-2 | 天然产物（标准品 ...
rabusertib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic ...
Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with ...
Loss of PARP14 sensitizes cells to inhibitors of the ATR-CHK1 pathway ...
CHK1 inhibition induces elevated γ-H2AX and RPA phosphorylation in CALR ...
In vivo validation of combined targeting of irinotecan and CHEK1 in ...
Heatmap and concentration response curves for the addition of the Chk1 ...
CHK1 inhibitors selectively reduce the proliferation of cells carrying ...
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA ...
Full article: Repeated treatments of Capan-1 cells with PARP1 and Chk1 ...
Molecular pathway analysis of cell cycle regulators indicated CDK1 as ...
Statistical Assessment of Drug Synergy from In Vivo Combination Studies ...
Chk1 inhibition results in an increasing S-phase population due to ...
CHK1 inhibition sensitizes GBM cells to triapine Treatment (A-B) Cell ...
Inhibition of CHEK1 and WEE1 re-sensitize carboplatin-resistant 468-R ...
| The CHK inhibitor, prexasertib, is cytotoxic to MYBL2 High lung ...
CHK1 siRNA and additional CHK1 inhibitors enhance CPX-351-induced ...
Tumor-specific cytotoxicity through small molecule inhibition of Chk1 ...
Chk1 inhibition initiates caspase-activation in sensitive cell lines ...
Prexasertib HCl (LY2606368) | 99.88%(HPLC) | In Stock | Chk inhibitor
Chk inhibitors | checkpoint kinase | cancer | function | gene | mutation
In vitro validation of combined targeting of TOP1 and CHEK1 in colon ...
Effect of CHK1 inhibitors on CPX-351-induced apoptosis in additional ...
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to ...
Tyrosine kinase inhibitors target ABCG2 function. A Representative ...
Low-molecular-weight cyclin E (LMW-E) increased sensitivity to drugs ...
Identification of a Proteolysis‐Targeting‐Chimera that Addresses ...
《自然》重磅：史上最大数据库，揭秘抗癌药联用的秘诀_手机搜狐网
RRM2 inhibition induces CHK1-mediated replication stress response ...
CHK1 inhibitor | Chk | TargetMol
Tyrosine kinase inhibitors sensitize Hs578T cells to transcriptional ...
FOXP1 phosphorylation antagonizes its O-GlcNAcylation in regulating ATR ...
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in ...
Structures of the allosteric CHK1 inhibitors 26-28 and the crystal ...
Checkpoint activation | Chk Inhibitor Review
Chk抑制剂 | Chk Inhibitor
AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a ...
Tyrosine kinase inhibitors synergize with THZ531 to halt TNBC ...
A recent update on small‐molecule kinase inhibitors for targeted cancer ...
New article from the Laboratory of Pharmacogenomics: miR-195-5p/CHEK1 ...
Prexasertib (LY2606368) | Chk inhibitor | CAS 1234015-52-1 | Selleck
Inhibiting checkpoint kinase 1 (CHK1) affects spindle morphology and ...
CHK-IN-1 | Chk | TargetMol
Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its ...
High-throughput drug target discovery using a fully automated ...
LY2880070 | Chk inhibitor | CAS 1375637-35-6 | Selleck
Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a ...
Chk | 细胞周期 | TargetMol
Small cell lung carcinoma cell line screen of etoposide/carboplatin ...
Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors ...
LY2603618 Supplier | CAS 911222-45-2 | Focus Biomolecules
AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a ...
Systematic screening identifies ABCG2 as critical factor underlying ...
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo ...
